Zurich Cantonal Bank’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,893
| Closed | -$127K | – | 2684 |
|
|
2024
Q4 | $127K | Buy |
+11,893
| New | +$127K | ﹤0.01% | 2349 |
|
|
2022
Q2 | – | Sell |
-1,282
| Closed | -$11K | – | 2931 |
|
|
2022
Q1 | $11K | Hold |
1,282
| – | – | ﹤0.01% | 2703 |
|
|
2021
Q4 | $12K | Hold |
1,282
| – | – | ﹤0.01% | 2889 |
|
|
2021
Q3 | $22K | Hold |
1,282
| – | – | ﹤0.01% | 2774 |
|
|
2021
Q2 | $20K | Hold |
1,282
| – | – | ﹤0.01% | 2578 |
|
|
2021
Q1 | $25K | Hold |
1,282
| – | – | ﹤0.01% | 2510 |
|
|
2020
Q4 | $23K | Hold |
1,282
| – | – | ﹤0.01% | 2568 |
|
|
2020
Q3 | $25K | Hold |
1,282
| – | – | ﹤0.01% | 2452 |
|
|
2020
Q2 | $33K | Hold |
1,282
| – | – | ﹤0.01% | 2336 |
|
|
2020
Q1 | $23K | Hold |
1,282
| – | – | ﹤0.01% | 2316 |
|
|
2019
Q4 | $43K | Sell |
1,282
-1,139
| -47% | -$38.2K | ﹤0.01% | 2230 |
|
|
2019
Q3 | $58K | Hold |
2,421
| – | – | ﹤0.01% | 1938 |
|
|
2019
Q2 | $87K | Hold |
2,421
| – | – | ﹤0.01% | 1704 |
|
|
2019
Q1 | $89K | Buy |
2,421
+1,282
| +113% | +$47.1K | ﹤0.01% | 1648 |
|
|
2018
Q4 | $49K | Hold |
1,139
| – | – | ﹤0.01% | 2041 |
|
|
2018
Q3 | $54K | Hold |
1,139
| – | – | ﹤0.01% | 2116 |
|
|
2018
Q2 | $57K | Buy |
+1,139
| New | +$57K | ﹤0.01% | 2048 |
|